PARTNERSHIP LEVERAGES IPSC-BASED BETA CELLS FROM EVOTEC’S QRBETA INITIATIVE COMBINED WITH SERNOVA’S PROPRIETARY IMPLANTABLE CELL POUCH™ DEVICE THE GOAL IS THE DEVELOPMENT AND COMMERCIALISATION OF AN OFF-THE-SHELF BETA CELL REPLACEMENT THERAPY FOR INSULIN-DEPENDENT DIABETES EVOTEC MAKES STRATEGIC € 20 M EQUITY INVESTMENT IN SERNOVA EVOTEC/SERNOVA JOINT CONFERENCE CALL AND WEBCAST […]
functional
Ethics statement This study design was approved by the Hirosaki University Hospital Institutional Review Board (Protocol Number Num. 2017-026). Written informed consent was obtained from all the patients in this study. All experiments were performed in accordance with relevant guidelines and regulations. No animal experiments were conducted in this study. […]